The non-tuberculous mycobacteria (NTMs) are environmental organisms and opportunistic pathogens, posing a particular risk for those with underlying lung disease or immunosuppression. These infections are extraordinarily difficult to treat. We are applying some of the tools we’ve developed to study TB to this group of organisms, in order to better understand their unique biology with the ultimate aim of discovering new therapeutics.